Shenzhen Macrolux Medical Technology Co., Ltd. (hereinafter referred to as “Macrolux”) recently announced the completion of its Series A round by securing nearly CNY100 million, which is led by Legend Capital. Founded in October 2020 and headquartered in Shenzhen, Macrolux is a medical technology company focusing on innovative solutions for endoscopic interventional diagnosis and treatment. Macrolux’s founding team is formed from experts from leading medical device companies in China and has more than a decade of experience in product development, global marketing and the production management of endoscopes and minimally invasive surgical devices. With a vision of detecting diseases earlier and offering patients better treatments, Macrolux is committed to providing the world with endoscopic interventional diagnosis and treatment solutions covering departments including urology, respiration, and digestion by leveraging its engine for innovation-driven development.
Regarding this fundraising round, ZHANG Weiqiang, General Manager of Macrolux, said: “I’d like to extend my sincere gratitude to all the investors for their trust in Macrolux. Disposable electronic endoscopes are an early market experiencing rapid growth. With years of concentrating on the product development and technological innovation of disposable endoscopes, Macrolux has formed strong competitiveness in many aspects and aims to introduce solutions to the world that better meet customer needs relying on our ten more years of technology accumulation in the industry.”
Joe ZHOU, Managing Director of Legend Capital, said: “Legend Capital has focused on endoscopic diagnosis and treatment, which is a development direction of minimally invasive medical treatment. It is noticed that disposable endoscopes have solved the sore points of traditional medical devices in multiple application scenarios and have begun to penetrate rapidly in recent years. All the functional teams of Macrolux are experienced and have worked in a balanced way for a long time and shared complete commercialization experience from scratch to impressive performance. We are honored to cooperate with the team and look forward to the company’s innovative series of products accelerating penetration into clinical applications to benefit patients globally.”
Legend Capital has long been paying attention to the investment in the field of medical devices and diagnostics with a focus on three major themes: first, major diseases, especially the unmet clinical needs of chronic diseases; second, the first and uniqueness in technology, which enables a company to become or have the potential to become a leading player in subdivided industries; the third is the “device +” investment opportunities brought by the integration of medical devices and interdisciplinary technologies such as AI, IoT and Big Data.
At present, Legend Capital has invested in numerous leading companies in the subdivided industries, including Careray Digital Medical Technology (688607.SH), Axonics (AXNX), New Horizon Health (06606.HK), Wuhan Easy Diagnosis Biomedicine (002932.SZ), Berry Genomics (000710.SZ), Aohua Photoelectricity Endoscope (688212.SH), Chemclin Diagnostics (688468.SH), Bio-heart Biological (02185.HK), STAR Sports Medicine, ET Healthcare, GKHT Medical Technology, Hailai Xinchuang Medical Technology, Yeasen Biotechnology, and Dearer Medical.
About Legend Capital
Founded in 2001, Legend Capital is a leading VC&PE investor focusing on the early-stage and growth-stage opportunities in China, with offices across Beijing, Shanghai, Shenzhen, Hong Kong, and Seoul, Korea.
It currently manages USD and RMB funds of over US$10 billion in commitments, and has invested in around 600 companies, covering technology, healthcare, consumer, enterprise service and intelligent manufacturing sectors. Rooted in China, Legend Capital participated in the rise of many world-leading companies by solid investment coverage and systematic post-investment value-add. Over the years, Legend Capital has also become a widely recognized name in bridging key resources in China and overseas through cross-border activities, and a valuable partner to Chinese and overseas investors.
Legend Capital values long-term sustainable investment and incorporates ESG into its long-term development strategy. As a UNPRI signatory since November 2019, Legend Capital is among the first group of top VC/PE firms in China to join the initiative.
For more information, please visit www.legendcapital.com.cn/index_en.aspx and follow us on LinkedIn @Legend Capital (https://www.linkedin.com/company/legend-capital).
Los Angeles-based real estate merchant bank expects to originate $500 million on behalf of capital providers
LOS ANGELES – Jan. 24, 2023 – PRLog — Dekel Capital has launched Dekel Correspondent Lending (DCL), which on behalf of capital providers including a global asset manager and large European bank, will originate balance sheet and CMBS loans for the acquisition, refinancing and recapitalization of commercial real estate assets including build-to-rent and single family rentals. Real estate finance veteran Vishal Vanjani joins the firm as Managing Director to lead the new initiative along with Ben Markiles who joins the firm as Associate, announced Dekel Capital Principal and Founder Shlomi Ronen.
DCL adds to the Los Angeles-based real estate merchant bank’s suite of services that provide real estate investors and owners with financial solutions across the entire capital stack including permanent loans, B-notes, mezzanine financing, preferred equity and joint venture equity.
“Vishal and Ben bring to Dekel a variety of special lender relationships that most borrowers and brokers don’t have access to,” said Ronen. “We expect to originate approximately $500 million through our DCL platform and combined with our debt advisory and JV equity services, we will help our clients manage the current crisis, take advantage of the market dislocation and prepare for the future.”
“Unlike other correspondent programs that are generally focused on ‘in-the-box’ financing, we will be able to originate in-house a variety of non-recourse loans with short-term, floating-rate and long-term, fixed rate capital,” added Vanjani. “Our partners are looking to us to bring them opportunities with strong underlying dynamics in need of intelligent and patient capital. Being part of Dekel allows us to do that. Working with Shlomi and his team, we will be able to structure financing for the most complex transactions.”
Vanjani and Markiles come to Dekel from CION Investments, where they ran the alternative investment manager’s real estate capital markets program.
Vanjani has originated more than $15 billion over the course of his 28-year career in real estate finance, most notably running West Coast operations for Natixis and Pacific Western Bank (formerly CapitalSource). Prior to CION, he was President of Greenbridge Finance, the financing arm of Greenbridge Management. Vishal earned a B. S. in Business Administration with an emphasis in Real Estate Finance from the University of Southern California where he continues to serve as a board member of and an active participant in the USC Lusk Center for Real Estate.
Markiles began his career at Deutsche Bank originating CMBS and bridge debt out of the firm’s Los Angeles office. He later joined LoanCore Capital in its San Francisco office assisting in the origination of real estate debt across the United States. A graduate of Tufts University with a B.S. in Quantitative Economics, Markiles has originated approximately $2 billion over the course of his career.
About Dekel Capital
About Dekel Capital Dekel Capital is a Los Angeles-based real estate merchant bank with proven expertise in capital market advisory and private equity in commercial real estate. The firm serves an elite group of commercial real estate operators, investors and developers with an exclusive, boutique approach, allowing them to create tailored solutions that address unique capital challenges. For more information, please visit http://www.dekelcapital.com.
Contact Bruce Beck DB&R Marketing Communications, Inc. ***@dbrpr.com
LOS ANGELES – Jan. 9, 2023 – PRLog — Tova Capital has acquired a fully occupied 34,500-square-foot retail complex near Downtown Long Beach, CA, in a $6.2 million off-market transaction.
The retail property is located on a nearly one-acre site at 205-233 E. Anaheim Street, between Long Beach Boulevard and Pacific Avenue, the city’s main north/south arterials and transit lines. The property consists of two approximately 17,000-square-foot single-story buildings occupied by a popular brewery, Trademark Brewing and climbing gym Long Beach Rising, under long-term leases. The property benefits from its prime location across the street from two recently completed senior and affordable multifamily projects and is adjacent to a future 36-unit townhome development.
The retail property lies within the Transit Node High zone of the city’s Midtown Specific Plan, which was created to encourage housing density along the transit stops on Long Beach Blvd. The Midtown Specific Plan and Downtown Plan have led to over 2,100 housing units being delivered over the past five years in the downtown Long Beach submarket.
“The Downtown and Midtown Specific Plans have done their job of luring institutional investors and developers to build much needed quality housing in the submarket including market-rate, affordable and senior housing,” said Ron Harari, president and CEO of Tova Capital. “Our tenants will continue to benefit from the new residents moving into the area.”
Retail rents in Long Beach has grown by 2.2% over the past 12 months. Downtown Long Beach has been convincingly strong, if not transformational as retail rents are 30.9% higher than they were a decade ago, according to Tova Capital Vice President Zach Boren.
“This was a tremendous opportunity to acquire a cash-flowing retail asset at a very low basis,” said Boren. “Given the challenging credit markets, we were able to secure attractive seller financing, which allowed the deal to make sense in a market with few transactions occurring.”
Long Beach with a population of more than 450,000 is one of the 50 largest cities in the United States. Situated on the Southern California coast between Los Angeles and Orange Counties, it is home to the Ports of Los Angeles and Long Beach, the country’s largest global supply chain channel. Other demand drivers include its popular public spaces, parks and waterfront, educated work force and many tourist attractions including the Queen Mary and the Aquarium of the Pacific.
Tova Capital plans a long-term hold of the retail property, which is its first investment in Long Beach.
Jared Swedelson from NAI Capital represented Tova, while the seller was represented by Sheva Hosseinzadeh from Coldwell Banker Commercial BLAIR.
About Tova Capital Tova Capital, Inc. (http://www.tovacapital.com) is a Los Angeles-based real estate investment and development company focusing on value-add commercial acquisitions in prime Southern California markets. Founded in 2017, the firm seeks investment opportunities to rehabilitate and reposition older industrial and office buildings into creative office, entitle land for higher and better uses and construct ground up development. Tova manages all aspects of the development process including acquisition, construction, financing and disposition.
Contact Bruce Beck DB&R Marketing Communications, Inc. ***@dbrpr.clom
Hafezi Capital International Consulting developed a Feasibility Study for Sudan Children’s Cancer Organization in Khartoum, Sudan. The analysis was to undertake an in-depth research and viability of a Pediatric Oncology Hospital in Khartoum, Sudan. The analysis required new statistical models to be developed given that the number of pediatric cancer cases is under-reported within Sudan. Hafezi Capital’s Feasibility Study analysis reviewed the medical and geographic literature on issues related to Pediatric Cancer, treatment and accessibility and provided a final model for its continued survivability. The research further examined the potential of increasing the current 16% survival rate of pediatric cancer patients to the baseline of 83% within five years, as has been proven by other similar programs throughout developing countries.
The Feasibility Study analyzed the costs associated with the project’s development, medical and support costs, housing costs, insurance, patient affordability, increases in estimated survivability rate, and economic data. “The study was designed to be a thorough analysis of the Sudanese need for pediatric oncology and how Sudan Children’s Cancer Organization can have a strong impact in Khartoum. Based on our analysis, at minimum, the organization can save over 2,000 children with their program in the coming decade and increase survivability to above 80%,” said Babak Hafezi, the CEO of Hafezi Capital International Consulting. The goal of this project has always been to help develop a process by which the most vulnerable people in the world – children with different types of cancer – have the ability to not only survive but also thrive in Sudanese society.
About Hafezi Capital
Hafezi Capital is a boutique consulting firm with headquarters in McLean, Virginia, and offices across the primary center of business and finance throughout the United States, Europe, Latin America, the Middle East, and Australia-Asia. Hafezi Capital’s extensive experience and focus rest on project review and analysis, financial and organizational structure, market research, economic analysis, country analysis, project analysis, and project viability. HafeziCapital has worked with Startups to Fortune 100 Companies in virtually every industry: manufacturing, agriculture, infrastructure, oil and gas, real estate development, hospital, city development, and technology. Since its inception, Hafezi Capital has been dedicated to providing high-quality insights into business analysis and structure and fully understands how to bring viable and long-lasting solutions to the challenges its clientele faces in a competitive global market.
Contact Information: Media Relations +1 (703) 752-0200 media@hafezicapital.com
Hafezi Capital LLC Babak Hafezi 703-752-0200 www.hafezicapital.com
Legend Capital Portfolio Company Bespin Global, a Korea-headquartered cloud services company, has recently completed its Series D round financing of USD100 million, which will be used mostly for acquisitions. Concurrent with the investment, the investor, e& Enterprise, a leading digital services provider in UAE (formerly Etisalat Digital), and Bespin Global will form a joint venture that will serve customers in the Middle East, North Africa and Pakistan.
John HanJoo Lee, CEO and co-founder of Bespin Global said, “By combining forces with e& enterprise in the METAP region, we are bringing much needed cloud managed services to the region where cloud adoption is about to explode. e& enterprise has deep customer relationships and the trust of its customers and Bespin Global has the deep cloud management capabilities. Together, we can accelerate cloud adoption in the region. Additionally, we welcome e& as our shareholder. It’s a clear validation of our track record as a trusted cloud managed services provider on the global stage.”
Bespin Global helps its customers in their digital transformation by providing cloud migration, cloud management and related SaaS offerings. It is the first multi-cloud managed service provider in East Asia with partnerships with Amazon Web Services, Microsoft Azure, Google Cloud, Aliyun, Tencent Cloud, and Naver Cloud.
The company has offices in 9 countries including Korea, China, Japan, Singapore, Vietnam, Indonesia, the US, UAE, and Saudi Arabia. It has over 1,700 customers which range from large enterprises to fast growing startups.
Legend Capital led Bespin Global’s Series A financing in 2017, and continued to invest in the company’s Series B financing in 2019. As an early investor, Legend Capital has provided support and help to Bespin Global in global cooperation, enterprise management and subsequent financing, to promote Bespin Global’s development.
In 2020, Legend Capital introduced Serverworks, a leading AWS Cloud integrator in Japan, to Bespin Global. The two companies established a joint venture in September 2021, entering the Japanese market officially.
John HanJoo Lee, CEO and co-founder of Bespin Global said, “It was Legend Capital that first introduced us to the UAE investors that led to the successful funding round with e&. Many venture capital firms talk about adding value, but only a few actually do. Legend Capital continues to add value beyond just capital. We are so lucky to have such a great partner as our investor.”
About Legend Capital
Founded in 2001, Legend Capital is a leading VC&PE investor focusing on the early-stage and growth-stage opportunities in China, with offices across Beijing, Shanghai, Shenzhen, Hong Kong, and Seoul, Korea.
It currently manages USD and RMB funds of over US$10 billion in commitments, and has invested in around 600 companies, covering technology, healthcare, consumer, enterprise service and intelligent manufacturing sectors. Rooted in China, Legend Capital participated in the rise of many world-leading companies by solid investment coverage and systematic post-investment value-add. Over the years, Legend Capital has also become a widely recognized name in bridging key resources in China and overseas through cross-border activities, and a valuable partner to Chinese and overseas investors.
Legend Capital values long-term sustainable investment and incorporates ESG into its long-term development strategy. As a UNPRI signatory since November 2019, Legend Capital is among the first group of top VC/PE firms in China to join the initiative.
For more information, please visit www.legendcapital.com.cn/index_en.aspx and follow us on LinkedIn @Legend Capital (https://www.linkedin.com/company/legend-capital).
Contact